








What is cerebrovascular disease?
Cerebrovascular disease refers to any of a number of brain dysfunctions which are caused by disease of the blood vessels in the brain. These dysfunctions are classified as: embolisms, aneurysms, or low-flow conditions. These can result in different types of strokes.
Hypertension, or high blood pressure, is the most significant cause of cerebrovascular disease. It causes the vessel linings to become damaged, which the body then tries to repair by concentrating platelets in the injured area. This, in turn causes the vessels to become more narrow and stiff, making further damage to them much more likely. Thus, continued hypertension can permanently change blood vessels, making them then much more vulnerable to future changes in blood pressure.
For example, if your blood pressure is reduced, as during sleep, not enough blood travels through the narrowed blood vessels, which can cause an ischemic stroke. While, conversely, activity or excitement can cause a rise in blood pressure, which puts too much pressure on the vessels and can cause a hemorrhagic stroke.
We at Qilu Pharmaceutical can provide a comprehensive range of drugs for the treatment of various cerebrovascular diseases.
What is cardiovascular disease?
Cardiovascular disease is a class of diseases that have to do with the heart or blood vessels. Though it technically is more encompassing, it is commonly used to refer to diseases relating to atherosclerosis (arterial disease). There are a variety of treatments used by numerous specialists, depending on which organs are being treated.
Studies show that the incidence of heart disease is well on the rise, and it affects countries all over the globe. There is more and more emphasis on the need to take steps to prevent this disease from an early age, and more types of cardiovascular drugs are also being produced to treat it.
We at Qilu Pharmaceutical can provide comprehensive range of cerebrovascular and cardiovascular for the prevention and management of cerebrovascular and cardiovascular diseases. Over 50 years of experience in drug development and manufacturing enables us to be a GMP certified, cerebrovascular and cardiovascular drug manufacturer and supplier in China. Additionally, our medicines are approved by USFDA, EDQM, MHRA (UK), and MCC (South Africa), as well as the drug-regulatory authorities of many other countries.
Our medications for cerebrovascular and cardiovascular patients, include: Citicoline Sodium capsules, Buflomedil Hydrochloride injections, Warfarin Sodium tablets, Isosorbide Mononitrate injections, Monosialotetrahexosylganglioside Sodium injections, and Carvedilol tablets.
If you have a need for our products, please don't hesitate to contact us. We would be happy to answer any questions you may have.